Leveraging Microbiome Science From the Bedside to Bench and Back: A Nursing Perspective.
Leveraging Microbiome Science From the Bedside to Bench and Back: A Nursing Perspective.
复制标题
DOI:
10.1097/nnr.0000000000000475
复制
发表时间:
2021
期刊:
影响因子:
2.5
通讯作者:
Wallen GR
中科院分区:
文献类型:
--
作者:
Maki KA;Joseph PV;Ames NJ;Wallen GR
Nurses are, and have been, trained to evaluate patients as more than a sum of their parts and to appreciate the complexities and interconnected nature of multiple body systems on human health (Knisely & Draucker, 2016). Although this method of patient evaluation and multisystems-based approach is being adopted by many disciplines, including medicine (Wells et al., 2015), the multidimensional training required to study the role of the microbiome in human health from a nursing lens is not generally well understood. Many nurse scientists have advanced education in genetics and genomics from doctoral programs and postdoctoral training. This advanced training makes them well posed to be the link between preclinical microbiome research and clinical/translational research that facilitates improvements in clinical care and patient outcomes. A background in holistic care is foundational for the development of research hypotheses testing the effect of physical, mental, and environmental factors on the bacterial communities in the microbiome and how the microbiome may have implications for clinical interventions and patient health. With this generation of “bedside to bench and back” research, nurses are at the forefront of translational microbiome research. Viewing research from a nursing perspective allows nurse scientists to combine the patientcentered questions carved from their clinical experience with cutting-edge genomic technologies to understand complex human–microbiome–environment interactions (Figure 1). The microbiome is made up of the communities of bacteria that live in and on the human body and their collective genetic information (Ursell et al., 2012). Advances in microbial sequencing technologies have enhanced rapid knowledge accumulation of these microbial communities. The clinical and therapeutic potential of the microbiome has been witnessed by the explosion of research linking disruptions in the microbiome with disease (Gilbert et al., 2016; Lynch & Pedersen, 2016). Therapies centered on modulating the microbiome, such as fecal microbiota transplantation (“transplanting” stool from a healthy person to a diseased patient), have effectively treated complex clinical conditions such as Clostridium difficile colonization and colitis (Allegretti et al., 2019). The improvement of clinical outcomes, unmatched by standard antibiotic protocols (Allegretti et al., 2019), hints at the potential that microbiome therapeutics may have once we have a comprehensive understanding of the influence that these bacterial communities have on host physiology and the extent that microbiome disruption contributes to disease. Importantly, the connection of microbiome and human health supports the longstanding nursing philosophy that pathogenic changes in one body system influence overall homeostasis and well-being. Examples of disorders that are currently being explored by research teams led by nurses in relation to the human microbiome are preterm birth, sleep disruption, symptom profiles of irritable bowel syndrome, and aplastic anemia treatment complications. Preterm birth and infant morbidity are significant public health problems, and African American women are disproportionally affected. In an ongoing study funded by the National Institute of Nursing Research, researchers are studying the contribution of the oral, vaginal, and gut microbiome to the incidence of preterm birth (Corwin et al., 2017). Results from this research have rapid translational implications for clinicians if the unique biomarkers under investigation are able to identify African American women with preterm birth risk. These biomarkers could serve as therapeutic targets …